Email Subscription

Never miss the latest news and offers - subscribe now!

Never miss the latest news and offers - subscribe now!

Development of a Scalable Viral Vector Upstream Process for Gene Therapy

Genethon and Pall® Biotech have collaborated to demonstrate the benefits of the iCELLis® fixed-bed bioreactor as a platform for viral vector production.
Genethon and Pall® Biotech have collaborated to demonstrate the benefits of the iCELLis® fixed-bed bioreactor as a platform for viral vector production.
Learn More

Advanced Filtration Optimizes High-Viscosity Blow-Fill-Seal

What was putting a choke-hold on sterile filtration throughput? Spanish CMO Unolab switched to Pall’s polyethersulfone membrane filters and solved a challenging issue.
What was putting a choke-hold on sterile filtration throughput? Spanish CMO Unolab switched to Pall’s polyethersulfone membrane filters and solved a challenging issue.
Learn More

Single-Use Technologies In A 1000 Liter Plus Monoclonal Antibody Process

How to confirm that single-use manufacturing is feasible for mAb processes at a 1,000-liter plus scale? Pall helped Rentschler to find the answers.
How to confirm that single-use manufacturing is feasible for mAb processes at a 1,000-liter plus scale? Pall helped Rentschler to find the answers.
Learn More